ASKA Pharmaceutical Holdings Co.,Ltd.
4886
Rank in Stocks
#13552
ASKA Pharmaceutical Holdings Co.,Ltd. is a Japanese enterprise that operates... ASKA Pharmaceutical Holdings Co.,Ltd. is a Japanese enterprise that operates through its subsidiaries in three primary areas: pharmaceuticals, animal healthcare, and hormone testing services. The company's pharmaceutical division is dedicated to the research, development, production, and commercialization of medications, with a specific focus on endocrinology, obstetrics and gynecology, and urology. Within its animal health segment, ASKA manufactures, sells, imports, and exports a broad spectrum of veterinary products, such as medicines, medical equipment, animal feed and supplements, laboratory reagents, agricultural chemicals, industrial chemicals, hygiene products, and food items along with their raw materials. Beyond these activities, the company also performs clinical and biological testing and offers medical devices. Founded in 1920, ASKA Pharmaceutical Holdings Co.,Ltd. is headquartered in Tokyo, Japan.
Share Price
$13.43
Last synced: 2026-11-10
Market Cap
$381.94M
Change (1 day)
1.78%
Change (1 year)
1.62%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade ASKA Pharmaceutical Holdings Co.,Ltd. (4886)
Category
Healthcare
EPS for ASKA Pharmaceutical Holdings Co.,Ltd. (4886)
EPS as of September 2026 TTM: $1.16
According to ASKA Pharmaceutical Holdings Co.,Ltd.'s latest financial reports, its current EPS (TTM) is $1.16. At the end of 2025 the company had an EPS of $1.20, a decrease compared to its 2024 EPS of $1.76.
EPS history for ASKA Pharmaceutical Holdings Co.,Ltd. from 2005 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $1.16 | -3.30% |
| 2025 | $1.20 | -31.82% |
| 2024 | $1.76 | 55.77% |
| 2023 | $1.13 | -8.99% |
| 2022 | $1.24 | 43.85% |
| 2021 | $0.86 | 304.59% |
| 2020 | $0.21 | -61.67% |
| 2019 | $0.56 | -30.22% |
| 2018 | $0.80 | -15.66% |
| 2017 | $0.95 | 323.46% |
| 2016 | $0.22 | -37.48% |
| 2015 | $0.36 | 106.41% |
| 2014 | $0.17 | -59.49% |
| 2013 | $0.43 | 14,143.33% |
| 2012 | 0.00 | -100.89% |
| 2011 | $-0.34 | -1,058.64% |
| 2010 | $0.04 | -83.70% |
| 2009 | $0.22 | -82.69% |
| 2008 | $1.25 | 330.58% |
| 2007 | $0.29 | 83.22% |
| 2006 | $0.16 | 4.55% |
| 2005 | $0.15 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 460.27% |
DE
|
|
| $6.08 | 423.75% |
DE
|
|
| $1.55 | 33.63% |
JP
|
|
| $3.66 | 215.41% |
CH
|
|
| $0.45 | -61.22% |
IL
|
Questions about ASKA Pharmaceutical Holdings Co.,Ltd.'s earnings per share (EPS)
What is ASKA Pharmaceutical Holdings Co.,Ltd.'s earnings per share (EPS)?
ASKA Pharmaceutical Holdings Co.,Ltd.'s earnings per share (EPS) over the last twelve months is $1.16, as of Sep 2026.
What was ASKA Pharmaceutical Holdings Co.,Ltd.'s earnings per share (EPS) in 2025?
In 2025, ASKA Pharmaceutical Holdings Co.,Ltd.'s earnings per share (EPS) was $1.20, 31.82% less than in 2024 ($1.76).
How has ASKA Pharmaceutical Holdings Co.,Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, ASKA Pharmaceutical Holdings Co.,Ltd.'s earnings per share (EPS) went from $0.21 to $1.20, an average growth of 41.71% a year.
How does ASKA Pharmaceutical Holdings Co.,Ltd.'s earnings per share (EPS) compare with similar companies?
ASKA Pharmaceutical Holdings Co.,Ltd.'s earnings per share (EPS) ($1.16) is higher than that of 1 of the 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.